Scoulerine was found to be active as an inhibitor of ß-site amyloid precursor protein cleaving enzyme 1 (BACE1), which is a very promising target for the treatment of Alzheimer’s disease (AD)5. This evidence concerns the gene BACE1 and Alzheimer disease.